Background and Aims
Crohn’s disease (CD) recurrence following ileocolic resection (ICR) is common. We sought to identify blood-based biomarkers associated with CD recurrence.
Methods
CD patients undergoing ICR were recruited across six centres. Serum samples were obtained at post-operative colonoscopy. A multiplex immunoassay was used to analyse 92 inflammation-related proteins (Olink Proteomics). Bayesian analysis was used to identify proteins associated with increasing Rutgeerts score. Identified proteins were employed in receiver operating characteristic (ROC) analysis to examine ability to identify CD recurrence (Rutgeerts score ≥ i2). Existing single cell data was interrogated to further elucidate the role of identified proteins.
Results
Data from 276 colonoscopies in 213 patients were available. Median time from surgery to 1st and 2nd colonoscopy was 7 (IQR 6-9) and 19 (IQR 16-23) months, respectively. Disease recurrence was evident at 60 (30%) first and 36 (49%) second colonoscopies. Of 14 proteins significantly associated with Rutgeerts score, the strongest signal was seen for CXCL9 and MMP1. Among patients on anti-TNF, CXCL9 and CXCL11 were most strongly associated with Rutgeerts score. Both are CXCR3 ligands. Incorporation of identified proteins into ROC analysis improved the ability to identify disease recurrence as compared to C-reactive protein alone; area under the curve (AUC) 0.75 (95% CI: 0.66-0.82) vs. 0.64 (95% CI 0.56-0.72), p=0.012. Single cell transcriptomic data provide evidence that innate immune cells are the primary source of identified proteins.
Conclusions
CXCR3 ligands are associated with CD recurrence following ICR. Incorporation of novel blood-based candidate biomarkers may aid identification of CD recurrence.
Clostridium diffi cile associated infections: an updated viewClostridium diffi cile is an emerging anaerobic, spore forming pathogen, recognized as the etiological agent of ~ 30% of antibiotic associated diarrheas. Clinical symptoms can fl uctuate from mild to moderate diarrhea, pseudomembranous colitis and toxic megacolon. The incidence of C. diffi cile associated infections (CDAI) is ~ 1% of total hospitalized patients. CDAI has a mortality rate of ~1 to 5%, and a relapse rate of ~ 20%. The appearance of severe outbreaks of CDAI could be attributed to changes in the production of the two major virulence factors, the enterotoxins TcdA and TcdB, which produce massive epithelial damage. C. diffi cile spores play an essential role in transmission, initiation and persistence of CDAI. Recent advances in detection methods, development of novel therapies and prevention methods could allow a reduction on the frequency of CDAI. The objective of this review is to provide an updated view on the mechanisms of pathogenesis, epidemiology, risk factors, detection methods, treatment and prevention of CDAI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.